Rapid Tests Market

Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.

For people taking a test, the defining feature is that the result can usually be given within 20 or 30 minutes, which is often more convenient and can mean that many more people actually receive their test results.

Rapid Tests Market contains market size and forecasts of Rapid Tests in Global, including the following market information:

• Global Rapid Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Rapid Tests market was valued at 10820 million in 2021 and is projected to reach US$ 14440 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Over-the-counter (OTC) Rapid Test Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rapid Tests include Akers Biosciences, Inc., Abbott, Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc. and Quidel Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Rapid Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rapid Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rapid Tests Market Segment Percentages, by Type, 2021 (%)

• Over-the-counter (OTC) Rapid Test Product
• Professional Rapid Test Product

Global Rapid Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rapid Tests Market Segment Percentages, by Application, 2021 (%)

• Infectious Disease
• Cardiology
• Oncology
• Pregnancy and Fertility
• Toxicology
• Glucose Monitoring
• Others

Global Rapid Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rapid Tests Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Rapid Tests revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Rapid Tests revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Akers Biosciences, Inc.
• Abbott
• Becton, Dickinson and Company
• Bio-rad Laboratories, Inc.
• Cepheid, Inc.
• Hologic, Inc.
• Meridian Bioscience, Inc.
• OraSure Technologies, Inc.
• Quidel Corporation
• Roche Diagnostics